The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions
Alberto Palazzuoli, Gaetano Ruocco, Marco Pellegrini, Carmelo De Gori, Gabriele Del Castillo, Nicola Giordano, Ranuccio NutiDepartment of Internal Medicine and Metabolic Diseases, Cardiology Section, Le Scotte Hospital, University of Siena, Siena, ItalyAbstract: Anemia is a common finding in congest...
Saved in:
Main Authors: | Palazzuoli A (Author), Ruocco G (Author), Pellegrini M (Author), De Gori C (Author), Del Castillo G (Author), Giordano N (Author), Nuti R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients
by: V. A. Titova, et al.
Published: (2014) -
Interplay Of Serum Erythropoietin and Inflammatory Cytokine in Anemic Tuberculosis Patients
by: Rashmi Anant Kulkarni, et al.
Published: (2015) -
Clinical Research and Standard of Care-An Unresolved Question?
by: N.G. Tornieporth, et al.
Published: (2016) -
Effect of erythropoietin-stimulating agent on uremic inflammation
by: Tanaka Yuri, et al.
Published: (2012) -
CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE
by: V. N. Larina, et al.
Published: (2016)